ELIC — Elicera Therapeutics AB Share News
0.000.00%
Last trade - 00:00- SEK189.29m
- SEK171.42m
- SEK10.86m
Brief: Elicera Therapeutics Receives EU Funding
Brief: Elicera Concludes Preclinical Proof-Of-Concept Studies For Elc-201
Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 4.7 Mln
Brief: Elicera Therapeutics Q4 Operating Loss Narrows To SEK 2.14 Mln
Brief: Elicera Therapeutics Secures SEK 5 Million In Funding From Vinnova
Brief: Elicera Therapeutics Acquirer Patent From Immunicum
Brief: Elicera Therapeutics Enters Agreement With Baylor College Of Medicine
Brief: Elicera Q3 Operating Loss Widens To SEK 6.8 Mln
Brief: Elicera Therapeutics Enters Agreement With BionNTech